Services & Partnerships

Collaborating to scale precision cancer screening and diagnostic innovation.

Elebio partners with healthcare providers, laboratories, insurers, and strategic stakeholders to expand access to clinically validated, non-invasive cancer screening solutions.
Our services span medical laboratory operations, diagnostic technology deployment, and cross-border clinical and regulatory collaboration across Asia and selected international markets.

Our Services

Medical Laboratory Testing

Accredited medical laboratory testing services in Hong Kong, supporting clinical diagnostics and cancer risk evaluation with reliable, clinically actionable results.

Cancer Screening Solutions

Development and deployment of non-invasive urine-based cancer screening technologies, including PURE Index® for prostate cancer risk assessment.

Clinical Research Support

Clinical studies, biomarker validation, and translational research conducted with hospitals and academic partners.

Partnership Models

Collaboration on clinical application, test adoption, and patient referral pathways for cancer screening services.

Technology licensing and service integration to expand access to non-invasive cancer screening solutions.

Integration of screening services into preventive healthcare programs and wellness initiatives.

Singapore & Global Expansion

Singapore Clinical Operations

Singapore serves as a strategic hub for Elebio’s regional and international expansion, supporting service distribution, clinical trials, and regulatory collaboration with HSA.

Local service distribution
Clinical trial support
Regulatory compliance & submissions
Expansion into Japan, US, PRC

Interested in Collaboration?

We welcome collaboration with healthcare providers, laboratories, insurers, and research institutions.